NRAS are please to support a PhD student in Pharmacy at Keele University, UK, Mohammed Aladul who is undertaking research into biosimilars. As part of this research he is conducting an online survey of patient’s opinions attitudes and experiences on infliximab or etanercept biosimilars. Your participation and answers will help to inform future educational initiatives and highlight important issues for prescribers, healthcare mangers, and other stakeholders.
If you have rheumatoid arthritis and are currently being treated on infliximab (Remicade, Remsima, Inflectra or Flixabi) or etanercept (Enbrel or Benepali) you are eligible to participate in this research. It takes less than 10 minutes to complete the questionnaires.
Your participation is entirely voluntary. The data collected in this study are entirely confidential, and the website used for data collection is secure in order to ensure confidentiality.
To participate go to: surveymonkey.co.uk/r/keeleb...
If you do not have access to the internet, or prefer to answer the questionnaire on paper, you may request a paper survey by sending an e-mail to email@example.com or calling 01782734131.